Chemotherapy, AdjuvantCombined Modality TherapyNeoplasm StagingAdjuvants, ImmunologicTreatment OutcomeFreund's AdjuvantRadiotherapy, AdjuvantAdjuvants, PharmaceuticBreast NeoplasmsAluminum HydroxideAntineoplastic Combined Chemotherapy ProtocolsFluorouracilDisease-Free SurvivalImmunizationTamoxifenNeoplasm Recurrence, LocalAntineoplastic Agents, HormonalMice, Inbred BALB CAdministration, IntranasalVaccinesSurvival AnalysisCyclophosphamidePrognosisArthritis, ExperimentalAntibody FormationSurvival RateVaccines, SubunitImmunoglobulin GAntineoplastic AgentsLymphatic MetastasisTime FactorsLevamisoleFollow-Up StudiesVaccinationOvalbuminSqualeneImmunity, MucosalAromatase InhibitorsDrug Administration ScheduleSaponinsMethotrexateMice, Inbred C57BLCholera ToxinPolysorbatesDoxorubicinRetrospective StudiesCancer VaccinesAcetylmuramyl-Alanyl-IsoglutamineVaccines, SyntheticLeucovorinDrug Therapy, CombinationNeoadjuvant TherapyEpirubicinLymph NodesCisplatinAdenocarcinomaRandomized Controlled Trials as TopicHypersensitivity, DelayedReceptors, EstrogenVaccines, DNAMastectomyRats, Inbred LewKaplan-Meier EstimateBacterial VaccinesISCOMsClinical Trials as TopicColonic NeoplasmsLipid AAntimetabolites, AntineoplasticNitrilesAdministration, OralImmunity, CellularAdjuvants, AnesthesiaImmunity, HumoralAnthracyclinesAntigensInterferon-gammaTriazolesTh1 CellsReceptor, erbB-2Vaccines, InactivatedSpleenDendritic CellsHemocyaninT-LymphocytesInjections, SubcutaneousTegafurInfluenza VaccinesRectal NeoplasmsNeoplasm MetastasisDose-Response Relationship, ImmunologicCytokinesLymphocyte ActivationProportional Hazards ModelsAntibodies, Monoclonal, HumanizedQuillajaDrug CombinationsImmunotherapyAntibodies, BacterialImmunization, Secondary